• DNDi logo
  • COVID-19
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Hepatitis C
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi East Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi logo
  • DNDi logo
  • COVID-19
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Hepatitis C
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi East Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home

News & resources

Home

News & resources

filters
Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

By Disease

Topic

By Topic

Location

By Location

Date Range

By Year

1999 — 2020

Results

No results found. Please try using different filter option(s).

In the media
3 Mar 2021

Toute la planète doit être vaccinée

L'actualité
In the media
26 Feb 2021

Por qué en 9 años el Chagas podría dejar de ser una preocupación de salud pública mundial

Infobae
Scientific articles
22 Feb 2021

2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling

PLOS Neglected Tropical Diseases
HAT Platform newsletter 2021 thumbnail
Publications
22 Feb 2021

HAT Platform Newsletter No. 21

Scientific articles
13 Feb 2021

Blood parasite load as an early marker to predict treatment response in visceral leishmaniasis in Eastern Africa

Clinical Infectious Diseases
In the media
13 Feb 2021

Health Digest: The story of Dr. Monique Wasuna, Director DNDi Africa- Doctor’s Diary

KTN News
In the media
13 Feb 2021

En Afrique, la lutte contre les maladies tropicales négligées

RFI
In the media
10 Feb 2021

En Afrique, la lutte contre les maladies tropicales négligées mise à mal par le Covid-19

Le Monde Afrique
Scientific articles
8 Feb 2021

Drug-drug interaction study of benznidazole and E1224 in healthy male volunteers

Antimicrobial Agents and Chemotherapy
In the media
8 Feb 2021

Combate à pandemia ensina lições para erradicação das doenças tropicais negligenciadas

Agência FAPESP
In the media
7 Feb 2021

Esquecidos pela Medicina

O Globo
In the media
2 Feb 2021

Thailand joins 23 nations in a global awareness campaign by illuminating Navamindrabopitr 84th Anniversary Building to show support for World NTD Day 2021

Destination Thailand News
In the media
1 Feb 2021

Vernachlässigte Tropenkrankheiten – es trifft immer die Armen

Deutsche Welle
In the media
1 Feb 2021

Palmarès Prescrire 2020 des médicaments : trois médicaments primés

Prescrire
In the media
1 Feb 2021

ประเทศไทยจับมือ 23 ประเทศ จัดแคมเปญรณรงค์ “วันโรคเขตร้อนที่ถูกละเลย” ด้วยการประดับตกแต่งไฟอาคารนวมินทรบพิตร ๘๔ พรรษา รพ.ศิริราช

Mahidol University
In the media
1 Feb 2021

30 มกราคม 64 รำลึกปีที่ 2 ของ “วันโรคเขตร้อนที่ถูกละเลยโลก”

Bangkok Biz News
1 2 … 146 ›
loading
All
News
Press releases
Publications
Scientific articles
Statements
Stories
Videos
Viewpoints
HAT Platform newsletter 2021 thumbnail
Publications
22 Feb 2021

HAT Platform Newsletter No. 21

Scientific articles
22 Feb 2021

2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling

PLOS Neglected Tropical Diseases
Scientific articles
13 Feb 2021

Blood parasite load as an early marker to predict treatment response in visceral leishmaniasis in Eastern Africa

Clinical Infectious Diseases
Scientific articles
8 Feb 2021

Drug-drug interaction study of benznidazole and E1224 in healthy male volunteers

Antimicrobial Agents and Chemotherapy
Girl being examined by a doctor
News
1 Feb 2021

Innovation to reach the destination: World NTD Day 2021

Laboratory staff working
Viewpoints
28 Jan 2021

WHO 2030 NTDs Roadmap: how science and partnerships can support the fight to end neglected diseases

Father walking with a cane and holding his son's hand
Stories
28 Jan 2021

The innovation neglected patients deserve

Statements
25 Jan 2021

DNDi interventions at the 148th session of the WHO Executive Board

Scientific articles
21 Jan 2021

Collaborative virtual screening to elaborate an imidazo[1,2-a]pyridine hit series for visceral leishmaniasis

RSC Medicinal Chemistry
Scientific articles
21 Jan 2021

Novel linker variants of antileishmanial/antitubercular 7-substituted 2-nitroimidazooxazines offer enhanced solubility

ACS Medicinal Chemistry Letters
Viewpoints
18 Dec 2020

Gender and R&D: DNDi effectively mobilized

Scientific articles
30 Nov 2020

Ending deaths from HIV-related cryptococcal meningitis by 2030

The Lancet Infectious Diseases
1 2 … 82 Next »

Events

8-10 March 2021

Virtual conference

Africa Health Agenda International Conference 2021

11-12 March 2021

Virtual event

International Clinical Research (Trials) during COVID-19 era: Should we suspend or continue?

11 March 2021

Online webinar

JAGntd Webinar Series on NTDs: Mycetoma

15-19 March 2021

Virtual conference

DIA Europe 2021

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

DNDi logo
Facebook-f Twitter Instagram Linkedin-in Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By continuing to browse our website, you are agreeing to our use of cookies.CLOSECOOKIE POLICY